Concepedia

Stephanie Andrews

SA

Statistics

Publications

19

Citations

2.5K

H-Index

16

Active since

2001

Affiliations

Moffitt Cancer Center(Current)

University of California, San Francisco

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Duke Cancer Institute

Stephanie Andrews is an author at Moffitt Cancer Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2001–2023

19

Publications

19

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

Adil Daud, Ronald C. DeConti, Stephanie Andrews et al. · Journal of Clinical Oncology · 2008 · 688 citations

, , +16

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 560 citations · Full text

, , +17

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2020 · 486 citations · Full text

, , +17

Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating Factor

Adil Daud, Noweeda Mirza, Brianna Lenox et al. · Journal of Clinical Oncology · 2008 · 184 citations

, , +14

Caregiver burden and symptom distress in people with cancer receiving hospice care.

Stephanie Andrews · PubMed · 2001 · 100 citations

, , +17

1–5 of 19